CadilaHealthcare up on USFDA nod to acne gel

Cadila Healthcare gained 0.8% after the company received final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl Peroxide gel, used in the treatment of acne.

For more information on stock tips and quick free trial click here > 911 133 9000 Visit http://www.epicresearch.co

Connect with our social media sites

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Follow @Epic_Research

Posted in: Indian Market Tips